Medy-Tox Inc. (KOSDAQ:086900)
South Korea flag South Korea · Delayed Price · Currency is KRW
144,100
-2,500 (-1.71%)
Aug 8, 2025, 3:30 PM KST

Medy-Tox Revenue

Medy-Tox had revenue of 63.96B KRW in the quarter ending March 31, 2025, with 17.16% growth. This brings the company's revenue in the last twelve months to 237.99B, up 2.13% year-over-year. In the year 2024, Medy-Tox had annual revenue of 228.62B with 3.39% growth.

Revenue (ttm)
237.99B
Revenue Growth
+2.13%
P/S Ratio
4.32
Revenue / Employee
328.72M
Employees
724
Market Cap
1,029.04B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024228.62B7.50B3.39%
Dec 31, 2023221.12B26.02B13.34%
Dec 31, 2022195.10B10.23B5.53%
Dec 31, 2021184.87B44.04B31.27%
Dec 31, 2020140.83B-65.07B-31.60%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics4,898.69B
Celltrion3,662.23B
ALTEOGEN151.65B
SK Biopharmaceuticals578.00B
Yuhan2,114.76B
Peptron4.30B
HLB Co., Ltd.74.64B
PharmaResearch392.31B
Revenue Rankings